Guardant Competitors
| GH Stock | USD 107.11 2.26 2.16% |
Guardant Health vs Encompass Health Correlation
Excellent diversification
The correlation between Guardant Health and EHC is -0.58 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Guardant Health and EHC in the same portfolio, assuming nothing else is changed.
Moving against Guardant Stock
The Guardant Health's current Return On Equity is estimated to increase to 3.77, while Return On Tangible Assets are projected to decrease to (0.36). As of now, Guardant Health's Intangibles To Total Assets are decreasing as compared to previous years. The Guardant Health's current Debt To Assets is estimated to increase to 0.85, while Total Assets are projected to decrease to under 1.4 B.Guardant Health Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Guardant Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Guardant and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Guardant Health does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Guardant Stock performing well and Guardant Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Guardant Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EXAS | 1.31 | 0.71 | 1.97 | (13.41) | 0.00 | 1.38 | 24.01 | |||
| ICLR | 3.08 | (0.84) | 0.00 | (0.23) | 0.00 | 4.72 | 45.92 | |||
| RVTY | 1.79 | (0.03) | (0.01) | 0.02 | 2.08 | 4.52 | 11.58 | |||
| ASND | 2.01 | 0.20 | 0.06 | (0.55) | 2.27 | 4.74 | 12.80 | |||
| VTRS | 1.32 | 0.51 | 0.38 | 0.78 | 0.72 | 4.51 | 8.83 | |||
| QGEN | 1.34 | 0.27 | 0.17 | (0.49) | 1.05 | 2.86 | 19.34 | |||
| IONS | 1.52 | 0.14 | 0.08 | 0.20 | 1.51 | 3.19 | 7.31 | |||
| BBIO | 1.87 | 0.19 | 0.05 | 0.22 | 3.16 | 4.65 | 20.64 | |||
| SOLV | 1.23 | (0.04) | (0.02) | 0.00 | 2.09 | 2.87 | 11.06 | |||
| EHC | 1.11 | (0.11) | 0.00 | (0.11) | 0.00 | 2.70 | 7.57 |
Cross Equities Net Income Analysis
Compare Guardant Health and related stocks such as EXACT Sciences, ICON PLC, and Revvity Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EXAS | (3.6 M) | (28.7 M) | (52.4 M) | (46.5 M) | (100 M) | (157.8 M) | (167.2 M) | (114.4 M) | (175.1 M) | (213.1 M) | (823.6 M) | (595.6 M) | (623.5 M) | (204.1 M) | (1 B) | (207.9 M) | (218.3 M) |
| ICLR | 3.9 M | 22.9 M | 55.4 M | 102.8 M | 172.5 M | 239.5 M | 262.2 M | 281.5 M | 322.8 M | 374 M | 327.8 M | 153.2 M | 505.3 M | 612.3 M | 791.5 M | 910.2 M | 955.7 M |
| RVTY | 55.7 M | 1.2 M | 68.4 M | 167.9 M | 158 M | 212.5 M | 233.7 M | 113 M | 238.8 M | 227.6 M | 728.1 M | 943.2 M | 569.2 M | (118.4 M) | 295.8 M | 241.7 M | 163.4 M |
| ASND | 1.2 M | 1.2 M | 1.2 M | 4.1 M | (9.7 M) | (32.9 M) | (68.5 M) | (123.9 M) | (130.1 M) | (218 M) | (419 M) | (383.6 M) | (583.2 M) | (481.4 M) | (378.1 M) | (219 M) | (230 M) |
| VTRS | 20.7 M | 536.8 M | 640.9 M | 623.7 M | 929.4 M | 847.6 M | 480 M | 696 M | 352.5 M | 16.8 M | (669.9 M) | (1.3 B) | 2.1 B | 54.7 M | (634.2 M) | (729.3 M) | (692.9 M) |
| QGEN | 2.4 M | 96 M | 129.5 M | 69.1 M | 116.4 M | 130.1 M | 80.4 M | 40.4 M | 190.4 M | (41.5 M) | 359.2 M | 512.6 M | 423.2 M | 341.3 M | 83.6 M | 424.9 M | 446.1 M |
| IONS | (4.5 M) | (84.8 M) | (65.5 M) | (60.6 M) | (39 M) | (88.3 M) | (86.6 M) | 346 K | 273.7 M | 294 M | (487 M) | (28.6 M) | (269.7 M) | (366.3 M) | (453.9 M) | (408.5 M) | (388.1 M) |
| BBIO | (30.6 M) | (30.6 M) | (30.6 M) | (30.6 M) | (30.6 M) | (30.6 M) | (30.6 M) | (30.6 M) | (130.7 M) | (260.4 M) | (448.7 M) | (562.5 M) | (481.2 M) | (643.2 M) | (535.8 M) | (482.2 M) | (506.3 M) |
| SOLV | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.5 B | 1.3 B | 1.3 B | 479 M | 431.1 M | 409.5 M |
| EHC | (1.5 M) | 208.7 M | 185 M | 323.6 M | 222 M | 183.1 M | 247.6 M | 271.1 M | 292.3 M | 358.7 M | 284.2 M | 412.2 M | 271 M | 352 M | 455.7 M | 566.2 M | 594.5 M |
Guardant Health and related stocks such as EXACT Sciences, ICON PLC, and Revvity Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Guardant Health financial statement analysis. It represents the amount of money remaining after all of Guardant Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Guardant Health Competitive Analysis
The better you understand Guardant Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Guardant Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Guardant Health's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Guardant Health Competition Performance Charts
Five steps to successful analysis of Guardant Health Competition
Guardant Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Guardant Health in relation to its competition. Guardant Health's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Guardant Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Guardant Health's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Guardant Health, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Guardant Health position
In addition to having Guardant Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Military Industrial Thematic Idea Now
Military Industrial
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Guardant Health Correlation with its peers. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is there potential for Health Care Providers & Services market expansion? Will Guardant introduce new products? Factors like these will boost the valuation of Guardant Health. Market participants price Guardant higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.22) | Revenue Per Share | Quarterly Revenue Growth 0.385 | Return On Assets | Return On Equity |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Guardant Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.